Scalper1 News
Specialty drugmaker Endo International withdrew its offer for Salix Pharmaceuticals Monday after Valeant Pharmaceuticals International enlarged its buyout deal. Investors seemed happy, as all three stocks went up. Valeant (VRX) raised its offer to $173 a share cash, or $11.1 billion, up from the $158 a share the two companies agreed to last month. The new terms also added $100 million to the breakup fee, which now amounts to $7 a Scalper1 News
Scalper1 News